Retail Pharmacies Lead Distribution in FTD Treatments The frontotemporal disorders treatment market, addressing rare but impactful neurodegenerative diseases, is poised for steady growth. Valued at USD 343.8 million in 2022, it is projected to reach USD 451.4 million by 2028, up at a 4.6% CAGR (2022–28).
Frontotemporal Disorders Treatment Market
Request a sample copy of the research report:...